Health Watch Home
Health Care Value
Transparency Costs
Transparency Quallity
Health Care Competition
Freedom of Information
  Report an Incident
  Join Health Watch
 Search Health Watch
Subscribe to Health Watch USA's Newsletter

To contact Health Watch USA please  use the following E-Mail Address

Content in this website may be linked to, as long as the linking webpage and passage has a known and clearly stated author.


Big Pharma - The Next Bailout.   

  Seaman AM. Hospital-acquired MRSA infection rates falling: CDC. Reuters. Mon Sep 16, 2013 4:45pm EDT. Accessed on Sep. 9, 1016 from  
McNeill R, Nelson D, Abutaleb Y.  ‘Superbug’ scourge spreads as U.S. fails to track rising human toll.  Reuters.

Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013 Nov 25;173(21):1970-8. doi: 10.1001/jamainternmed.2013.10423. Hospital Compare Data Sets. Data Acquisition Dates 10/1/2014 to 9/30/2015.  The MRSA Hospital SIR is 0.93. Last accessed Sep. 11, 2016 from 

Landers T, Kavanagh KT. Is the Presidential Advisory Council on Combating Antibiotic Resistance missing opportunities? American Journal of Infection Control Am J Infect Control. 2016 Sep 2. pii: S0196-6553(16)30706-4. doi: 10.1016/j.ajic.2016.07.008. [Epub ahead of print] 

Burger D. The Ebola Crisis: Coordination of a Multi-Agency Response. Committee on Oversight and Government
Reform. U.S. House of Representatives. Oct. 24, 2014. Last accessed on Sep. 9, 2016 from 

Swanson A. Big pharmaceutical companies are spending far more on marketing than research. The Washington Post. Feb. 11, 2015. Accessed on Sep. 9, 2016 from 

CDC: 1 in 3 antibiotic prescriptions unnecessary. Press Release. Centers for Disease Control and Prevention. Accessed on Sep. 9, 1016 from 

Ornstein C, Groeer, L, and Jones RG. Dollars for Docs. How Industry Dollars Reach Your Doctors. ProPublica. Accessed on Sep. 9, 1016 from 

Ornstein C. Jones RG, Tigas M. Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds ProPublica. Accessed on Sep. 9, 1016 from 

DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin J, Dudley RA. Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Internal Medicine. The Wall Street Journal. Accessed on Sep. 9, 2016 from

Loftus P. Even Cheap Meals Influence Doctors’ Drug Prescriptions, Study Suggests The Wall Street Journal. Accessed on Sep. 9, 2016 from

Steinman MS, Schillinger D. Drug Detailing in Academic Medical Centers: Regulating for the Right Reasons, with the Right Evidence, at the Right Time. Am J Bioeth. 2010 Jan; 10(1): 21–23. Accessed on Sep. 9, 2016 from .

Fugh-Berman A, Ahari S. Following the Script: How Drug Reps Make Friends and Influence Doctors. Plos Medicine. April 24, 2007 Accessed on Sep. 9, 2016 from f="" target="_blank">

McKenna M. Pharma Industry Calls on Governments to Fund New Antibiotics. Germination. National Geogrpahic. Jan. 20, 2016. 
2016 White House Budege Factsheet  “An increase of over $100 million at BARDA for the development of new antibiotic therapies and diagnostics.” “Support for FDA efforts to streamline the development pathway to facilitate treatment of patients with unmet medical needs.”